Olmesartan as an add-on to Amlodipine in Hypertension

Clinical trial NCT00220233 · COMPLETED

Trial details

NCT number: NCT00220233
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2005-04-01
Enrollment: 632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.